Skip to main content

Guidance by Device Class

Overview

While most TGA guidance applies across device classes, some guidance is specific to particular classes or risk levels. This page organises key guidance by device class to help you quickly find what's most relevant to your device. For the full guidance index, see All Guidance by Topic.


All Device Classes (General)

Guidance that applies regardless of classification:

GuidanceLink
What is a medical device — TGA decision toolTGA
Understanding medical device definitionsTGA
Complying with Essential Principles (all EPs)TGA
Essential Principles Checklist templateTGA
Steps to supply — sponsorsTGA
Labelling requirements (EP 13)TGA
Understanding post-market responsibilitiesTGA
Reporting adverse eventsTGA
PRAC — Recalls procedureTGA

Class I (Including Is and Im)

GuidanceLink
Classification guidance (not IVDs)TGA (PDF)
How to determine if product is correctly Class ITGA
Declaration of Conformity for Class ITGA
Passing preliminary assessmentTGA

Key facts for Class I:

  • Manufacturer self-certifies — no third-party QMS certification required (except Is/Im)
  • Declaration of Conformity is the primary conformity assessment document
  • ARTG application assessed at lower scrutiny level
  • No mandatory audit (but risk-based audit possible)

Class IIa

GuidanceLink
Classification guidanceTGA (PDF)
Obtaining manufacturer evidenceTGA
Comparable overseas regulators evidence guideTGA
Application audit criteriaTGA

Key facts for Class IIa:

  • ISO 13485 QMS certification required
  • Comparable overseas regulator evidence (CE certificate or equivalent) accepted
  • Audit possible but not mandatory
  • Declaration of Conformity required

Class IIb

GuidanceLink
Classification guidanceTGA (PDF)
Comparable overseas regulators evidence guideTGA
Implantable device guidance (for implantable IIb)TGA
Patient implant cardsTGA
Annual reporting (implantable IIb)TGA

Key facts for Class IIb:

  • Full QMS + product-specific certificate required
  • Higher audit likelihood than Class IIa
  • Annual reporting for implantable Class IIb devices
  • Patient implant cards required for implantable devices

Class III

GuidanceLink
Comparable overseas regulators evidence guideTGA
Application audit criteria — mandatory audit appliesTGA
Clinical evidence guidanceTGA
Annual reporting — Class IIITGA
Patient implant cardsTGA
Reclassifying AIMDsTGA

Key facts for Class III:

  • Full QMS + comprehensive product design assessment required
  • Mandatory audit for applications supported by EU MDD or US 510(k)
  • Annual reporting required (minimum 3 years post-inclusion)
  • Patient implant cards mandatory
  • Highest clinical evidence expectations

Active and Software Medical Devices

GuidanceLink
Classifying active and software medical devicesTGA
Software and AI as medical devices — full hubTGA
Cybersecurity for medical devicesTGA
Software exclusion guidanceTGA

Key facts for Software/AI:

  • Must be in ARTG from November 2024 (grace period ended)
  • Classified based on severity of harm from incorrect output
  • EP 12.1 applies — IEC 62304 software lifecycle standard
  • Cybersecurity by design required
  • Post-market monitoring of AI performance essential

IVD Class 1

GuidanceLink
IVD overview and classificationTGA
Declaration of Conformity for Class 1 IVDTGA
In-house IVDs (Class 1)TGA

IVD Class 2

GuidanceLink
IVD overview and classificationTGA
Self-tests and point-of-care guidanceTGA
Blood glucose monitoring guidanceTGA

IVD Class 3

GuidanceLink
HIV self-tests guidanceTGA
Hepatitis B and C self-testsTGA
Chlamydia, gonorrhoea and syphilis self-testsTGA
Application audit criteria (mandatory for Class 3)TGA

IVD Class 4

GuidanceLink
IVD overview and classificationTGA
In-house Class 4 IVD guidanceTGA
Application audit criteria (mandatory for Class 4)TGA
TGA-NATA MoU for in-house IVDsTGA